nanafly |
2007-01-25 13:46 |
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ /axIIfx- ~T) Q$ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© )_/
5*Ly@ +cD!1IT: Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© >A@Y$. JK.ZdY% 1.Co-stimulators (or co-stimulating molecules) ^bEc6`eE "M|zv
2.NK-kB t|~YEQ #v<QbA 3.Immunoglobulin superfamily keB&Bjd& L#vI=GpL,r 4.antigen-presenting cell (APC) 2Ry1b+\ %/9
EORdeH 5.death domain /4xki_} q$aaA`E% 6.CCR and CXCR XoA+MuDzpo Qx [t/~ 7.Lectin (or mitogen) 8T(e.I }#X8@ 8.Clusters of differentiation, CD) jg?x&'u\) d6
W SL;$ 9.B7 family AE} )o)B }N*_KzPIa 10.Cytotoxic T lymphocyte, CTL) `F/Tv 5@L A<W6=5h 11.IL-15 and IL-15 receptor (IL-15R) 6P';DB +wkjS r`e 12.MHC restriction D}vmwg@3 +"1NC\<* 13.Affinity-chromatography qbv#I; 8jyG"%WO 14.Cyctosprin A, CsA J9=m]R8T :H c0b= 15.Antibody-dependent cell-mediated cytotoxicity, ADCC) |O"lNUW
~V$|i" ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© aXL{TD:] S%Us5`sd 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 uV=Qp1~ ,u/aT5\_ 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ 95z]9UL 0pbtH8~ 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 sq;s]@~ 3"P }n Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© =MvjLh"s U{VCZ*0cj ÃâÒßѧרҵ£º 0lv%`, t
89!Ihk 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 0$-xw >
ss/D^YS Ïû»¯ÄÚ¿Æ£º ?`4+cx}n X@f "-\ 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ yUp,NfS]o 0D&t!$Ibf ѪҺ²¡Ñ§×¨Òµ£º ~t~-A,1 ;vIrGZV< 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
|
|